Journal of Isfahan Medical School

Journal of Isfahan Medical School

Intra Operative Blood Salvage in Liver Transplantation: The Oncologic and Infectious Safety with an Emphasize on Hepatocellular Carcinoma - A Narrative Review

Document Type : Review Article

Authors
1 Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of General Surgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
10.48305/jims.v44.i874.1515
Abstract
Background: Liver transplantation is often associated with significant intraoperative bleeding, exposing patients to extensive use of allogeneic blood products. Intraoperative blood salvage (IBS) is a solution to mitigate this effect; however, its oncologic and infectious safety remains a matter of debate. This narrative review aims to synthesize the current evidence regarding the efficacy and safety of IBS and provide risk-based practical recommendations.

Methods: A critical search and synthesis of cohort studies, prospective investigations, and systematic reviews/meta-analyses was conducted, with a focus on: reduction in allogeneic blood product utilization, oncologic outcomes, infectious safety, and moderating factors such as leukocyte depletion filtration (LDF).

Findings: Selective application of IBS tailored to bleeding risk and surgical field conditions consistently reduces the need for allogeneic transfusion, and the hematologic quality of salvaged products is acceptable. In hepatocellular carcinoma, the body of evidence suggests that IBS —particularly with standard use of LDF— is comparable to allogeneic transfusion strategies in terms of recurrence and survival, although cautionary signals have been reported in high-risk subgroups, such as patients with elevated alpha-fetoprotein levels. From an infectious standpoint, in living donor liver transplantation, bile is frequently sterile and LDF effectively reduces contamination; however, in deceased donor transplantation, the performance of LDF may be inadequate in the presence of a high bacterial load.

Conclusions: IBS represents a safe and effective option for reducing allogeneic exposure in many liver transplant recipients. Decision-making in high-risk subgroups should be guided by individualized risk assessment.

Highlights

Mohammad Eslamian: Google Scholar

Keywords
Subjects

1.     Kazemi K, Shamsaeefar A, Nikoupour H, Nazari SS, Sheikhbahaei E, Esparham A, et al. The pringle maneuver for Budd-Chiari syndrome-related orthotopic liver transplantation: an experience from a large referral center. BMC Surg 2025; 25(1): 106.
2.     Nikoupour H, Sheikhbahaei E, Shamsaeefar A, Kazemi K, Eslamian M, Zefreh H, et al. Post-Metabolic Bariatric Surgery Cirrhosis and the Role of Liver Transplantation: A Report from a Referral Transplant Center. Obes Surg 2025; 35(6): 2111–20.
3.     Massicotte L, Thibeault L, Roy A. Classical Notions of Coagulation Revisited in Relation with Blood Losses, Transfusion Rate for 700 Consecutive Liver Transplantations. Semin Thromb Hemost 2015; 41(5): 538–46.
4.     Pinto MA, Chedid MF, Sekine L, Schmidt AP, Capra RP, Prediger C, et al. Intraoperative cell salvage with autologous transfusion in liver transplantation. World J Gastrointest Surg 2019; 11(1): 11–8.
5.     Lima CM de F, Rebouças TO, Carlos LM de B, Oliveira JBF, Silva EL da, Alves JS, et al. Assessment of the need for routine intraoperative cell salvage in liver transplantation. Acta Cir Bras 2023; 38: e386423.
6.     Aijtink VJ, Rutten VC, Meijer BEM, de Jong R, Isaac JL, Polak WG, et al. Safety of Intraoperative Blood Salvage During Liver Transplantation in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Ann Surg 2022; 276(2): 239–45.
7.     Wang Z, Li S, Jia Y, Liu M, Yang K, Sui M, et al. Clinical prognosis of intraoperative blood salvage autotransfusion in liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis. Front Oncol 2022; 12: 985281.
8.     Han S, Kim G, Ko JS, Sinn DH, Yang JD, Joh JW, et al. Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma. Ann Surg 2016; 264(2): 339–43.
9.     Kwon JH, Han S, Kim D, Kuk JH, Cho H, Kim S, et al. Blood Salvage and Autotransfusion with Single Leukoreduction Does Not Increase the Risk of Tumor Recurrence after Liver Transplantation for Advanced Hepatocellular Carcinoma. Ann Surg 2022; 276(6): E842–50.
10.  Hinojosa-Gonzalez DE, Salgado-Garza G, Tellez-Garcia E, Escarcega-Bordagaray JA, Bueno-Gutierrez LC, Madrazo-Aguirre K, et al. Blood salvage and autotransfusion during orthotopic liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis. Clin Transplant 2024; 38(1): e15222.
11.  Yang M, Wei X, Shu W, Zhai X, Zhou Z, Cai J, et al. Influence of intraoperative blood salvage and autotransfusion on tumor recurrence after deceased donor liver transplantation: a large nationwide cohort study. Bile duct anastomosis does not promote bacterial contamination of autologous blood salvaged during living donor liver transplantation 2024; 110(9): 5652–61.
12.  Kim D, Han S, Kim YS, Choi GS, Kim J, Lee KW, et al. Bile duct anastomosis does not promote bacterial contamination of autologous blood salvaged during living donor liver transplantation. Liver Transpl 2022; 28(11): 1747–55.
13.  Kim D, Han S, Yang JD, Kwon JH, Choi GS, Kim JM, et al. Bacterial contamination of autologous blood salvaged during deceased donor liver transplantation: a prospective observational study. Sci Rep 2024; 14(1): 26785.
14.  Tan JKH, Menon NV, Tan PS, Pan TLT, Bonney GK, Shridhar IG, et al. Presence of tumor cells in intra-operative blood salvage autotransfusion samples from hepatocellular carcinoma liver transplantation: analysis using highly sensitive microfluidics technology. HPB (Oxford) 2021; 23(11): 1700–7.
15.  Weller A, Seyfried T, Ahrens N, Baier-Kleinhenz L, Schlitt HJ, Peschel G, et al. Cell Salvage During Liver Transplantation for Hepatocellular Carcinoma: A Retrospective Analysis of Tumor Recurrence Following Irradiation of the Salvaged Blood. Transplant Proc 2021; 53(5): 1639–44.
16.  Lee J, Park S, Lee JG, Choo S, Koo BN. Efficacy of intraoperative blood salvage and autotransfusion in livingdonor liver transplantation: a retrospective cohort study. Korean J Anesthesiol 2024; 77(3): 345–52.
17.  Liu X, Fan R, Lu Y, Kuang L, Yuan Q, Chen Y, et al. Influence of autologous blood transfusion in liver transplantation in patients with hepatitis B on the function and hemorheology of red blood cells. Exp Ther Med 2017; 14(2): 1205–11.
18.  Nasser A, Smith V, Campbell N, Rivers-Bowerman MD, Stueck AE, Costa AF, et al. Is hepatocellular carcinoma viability important when using intraoperative blood salvage during liver transplantation? Int J Gastrointest Interv 2023; 12(3): 145–51.
19.  Pinto MA, Grezzana-Filho TJM, Chedid AD, Leipnitz I, Prediger JE, Alvares-da-Silva MR, et al. Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma. Langenbecks Arch Surg 2021; 406(1): 67–74.
20.  Ivanics T, Shubert CR, Muaddi H, Claasen MPAW, Yoon P, Hansen BE, et al. Blood cell salvage and autotransfusion does not worsen oncologic outcomes following liver transplantation with incidental hepatocellular carcinoma: a propensity score-matched analysis. Ann Surg Oncol 2021; 28(11): 6816–25.
21.  Sutton TL, Pasko J, Kelly G, Maynard E, Connelly C, Orloff S, et al. Intraoperative autologous transfusion and oncologic outcomes in liver transplantation for hepatocellular carcinoma: a propensity matched analysis. HPB (Oxford) 2022; 24(3): 379–85.
22.  Nutu OA, Sneiders D, Mirza D, Isaac J, Perera MTPR, Hartog H. Safety of intra-operative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity score-matched survival analysis. Transpl Int 2021; 34(12): 2887–94.
Ko JS, Gwak MS, Kim GS, Na YR, Lee SK. The comparisons of hepatitis C virus RNA level between intraoperative blood salvage (Cell Saver) and systemic hepatitis C virus RNA kinetics during liver transplantation. Transplant Proc 2014; 46(5): 1430–1.
Volume 44, Issue 874
1st Week, October
September and October 2026
Pages 1515-1520

  • Receive Date 10 September 2025
  • Revise Date 22 April 2026
  • Accept Date 15 May 2026